PCA
INSP icon

Pallas Capital Advisors’s Inspire Medical Systems INSP Stock Holding History

Pallas Capital Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,979
Closed -$315K – 901
2025
Q1 		$315K Sell
1,979
-2,058
-51% -$372K 0.01% 583
2024
Q4 		$748K Buy
4,037
+233
+6% +$45.2K 0.03% 296
2024
Q3 		$743K Buy
3,804
+876
+30% +$152K 0.03% 277
2024
Q2 		$404K Buy
+2,928
New +$554K 0.02% 352

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pallas Capital Advisors's INSP Position: Q2 2025 in Review

Pallas Capital Advisors sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 1,979 shares — an estimated $315K sold.

Pallas Capital Advisors first reported a position in INSP in Q2 2024 and held it in 4 quarters. The position peaked at $748K in Q4 2024. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

  • Pallas Capital Advisors reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Pallas Capital Advisors sold 1,979 Inspire Medical Systems shares in Q2 2025, an estimated $315K.
  • Pallas Capital Advisors first reported a position in Inspire Medical Systems in Q2 2024 and held it in 4 quarters.
  • Pallas Capital Advisors's Inspire Medical Systems position peaked at $748K in Q4 2024.
  • 356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Pallas Capital Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.